Liposomal amphotericin B for treatment of leishmaniasis: from the identification of critical physicochemical attributes to the design of effective topical and oral …

F Frézard, MMG Aguiar, LAM Ferreira, GS Ramos… - Pharmaceutics, 2022 - mdpi.com
The liposomal amphotericin B (AmB) formulation, AmBisome®, still represents the best
therapeutic option for cutaneous and visceral leishmaniasis. However, its clinical efficacy …

Polyene antibiotics physical chemistry and their effect on lipid membranes; impacting biological processes and medical applications

T Haro-Reyes, L Díaz-Peralta, A Galván-Hernández… - Membranes, 2022 - mdpi.com
This review examined a collection of studies regarding the molecular properties of some
polyene antibiotic molecules as well as their properties in solution and in particular …

Self-assembling, supramolecular chemistry and pharmacology of amphotericin B: Poly-aggregates, oligomers and monomers

R Fernández-García, JC Muñoz-García… - Journal of Controlled …, 2022 - Elsevier
Antifungal drugs such as amphotericin B (AmB) interact with lipids and phospholipids
located on fungal cell membranes to disrupt them and create pores, leading to cell apoptosis …

[HTML][HTML] Natamycin sequesters ergosterol and interferes with substrate transport by the lysine transporter Lyp1 from yeast

M Szomek, P Reinholdt, HL Walther, HA Scheidt… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Natamycin is a polyene macrolide, widely employed to treat fungal keratitis and other yeast
infections as well as to protect food products against fungal molds. In contrast to other …

Potential lipid-based strategies of amphotericin B designed for oral administration in clinical application

X Zhong, J Yang, H Liu, Z Yang, P Luo - Drug Delivery, 2023 - Taylor & Francis
Amphotericin B (AmB) is regarded as a first-line therapy against life-threatening invasive
fungal infections. Due to its poor oral bioavailability, AmB is restricted to intravenous …

Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals

Q Zia, O Mohammad, MA Rauf, W Khan, S Zubair - Scientific reports, 2017 - nature.com
Biomimetic synthesis of nanoparticles offers a convenient and bio friendly approach to
fabricate complex structures with sub-nanometer precision from simple precursor …

In-silico approach as a tool for selection of excipients for safer amphotericin B nanoformulations

PA Todke, PV Devarajan - Journal of Controlled Release, 2022 - Elsevier
Safer and efficacious Amphotericin B (AmB) nanoformulations can be designed by
augmenting AmB in the monomeric or super-aggregated state, and restricting the …

Molecular organization, localization and orientation of antifungal antibiotic amphotericin B in a single lipid bilayer

W Grudzinski, J Sagan, R Welc, R Luchowski… - Scientific Reports, 2016 - nature.com
Amphotericin B is a popular antifungal antibiotic, a gold standard in treatment of systemic
mycotic infections, due to its high effectiveness. On the other hand, applicability of the drug is …

Preparation and characterization of spherical amorphous solid dispersion with amphotericin B

L Mehenni, M Lahiani-Skiba, G Ladam, F Hallouard… - Pharmaceutics, 2018 - mdpi.com
In the present study, new polymer microspheres of amphotericin B (AmB) were prepared by
a spray drying technique using cyclodextrin polymers (Poly-CD) to improve the solubility and …

Mechanism of binding of antifungal antibiotic amphotericin B to lipid membranes: an insight from combined single-membrane imaging, microspectroscopy, and …

E Grela, M Wieczór, R Luchowski… - Molecular …, 2018 - ACS Publications
Amphotericin B is a lifesaving polyene antibiotic used in the treatment of systemic mycoses.
Unfortunately, the pharmacological applicability of this drug is limited because of its severe …